Assignee
FORESEE PHARMACEUTICALS CO LTD
TW·13 granted patents·10 pending applications·16 citations·filing 2017–2025
Top patents by PatentIndex Score
23 records- 0189US10532102B2Pharmaceutical composition and methods of usesFORESEE PHARMACEUTICALS CO LTD·Filed 2017·Granted Jan 14, 2020·5 cites·3 claims
- 0286US11013810B2Pharmaceutical composition and methods of usesFORESEE PHARMACEUTICALS CO LTD·Filed 2020·Granted May 25, 2021·2 cites·21 claims
- 0386US10851089B2Matrix metalloproteinase (MMP) inhibitors and methods of use thereofFORESEE PHARMACEUTICALS CO LTD·Filed 2019·Granted Dec 1, 2020·4 cites·21 claims
- 0485US10646572B2Pharmaceutical compositions with enhanced stabilityFORESEE PHARMACEUTICALS CO LTD·Filed 2019·Granted May 12, 2020·1 cites·20 claims
- 0584US11306082B2Esters of dihydrotetrabenazineFORESEE PHARMACEUTICALS CO LTD·Filed 2018·Granted Apr 19, 2022·3 cites·14 claims
- 0684US10251956B2Methods of making pharmaceutical compositions with enhanced stabilityFORESEE PHARMACEUTICALS CO LTD·Filed 2017·Granted Apr 9, 2019·1 cites·12 claims
- 0779US12503460B2Matrix metalloproteinase (MMP) inhibitors and methods of use thereofFORESEE PHARMACEUTICALS CO LTD·Filed 2023·Granted Dec 23, 2025·0 cites·16 claims
- 0878US12133878B2Pharmaceutical compositions having a selected release durationFORESEE PHARMACEUTICALS CO LTD·Filed 2023·Granted Nov 5, 2024·0 cites·12 claims
- 0978US2025041378A1Method of Treating Hormonal Disorders Using Injectable LeuprolideFORESEE PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1077US2025018004A1Pharmaceutical Compositions having a Selected Release DurationFORESEE PHARMACEUTICALS CO LTD·Filed 2024·Application pending·0 cites
- 1176US2023270866A1Pharmaceutical composition and methods of usesFORESEE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1271US11628220B2Pharmaceutical composition and methods of usesFORESEE PHARMACEUTICALS CO LTD·Filed 2021·Granted Apr 18, 2023·0 cites·21 claims
- 1369US11673884B2Matrix metalloproteinase (MMP) inhibitors and methods of use thereofFORESEE PHARMACEUTICALS CO LTD·Filed 2020·Granted Jun 13, 2023·0 cites·20 claims
- 1467US12583844B2Matrix metalloproteinase (MMP) inhibitors and methods of use thereofFORESEE PHARMACEUTICALS CO LTD·Filed 2020·Granted Mar 24, 2026·0 cites·16 claims
- 1567US2022160817A1Pharmaceutical composition with improved stabilityFORESEE PHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 1664US2025163050A1Crystalline (+)-tetrabenazineFORESEE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1763US11717555B2Pharmaceutical compositions having a selected release durationFORESEE PHARMACEUTICALS CO LTD·Filed 2017·Granted Aug 8, 2023·0 cites·15 claims
- 1860US2023071314A1Polymeric compositions for sustained delivery of vmat2 inhibitorsFORESEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1958US2024269116A1Use of mmp inhibitors for treating acute respiratory distress syndromeFORESEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2057US2024390454A1Methods of manufacturing injectable sustained release formulationsFORESEE PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2157US2024156723A1Depot compositions for vesicular monoamine transporter 2 (vmat2) inhbitorsFORESEE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 2253US2025302739A1Long-acting injectable pharmaceutical compositions comprising biodegradable polymers for drug deliveryFORESEE PHARMACEUTICALS CO LTD·Filed 2025·Application pending·0 cites
- 2347US11419866B2Pharmaceutical composition for sustained release delivery of buprenorphineFORESEE PHARMACEUTICALS CO LTD·Filed 2019·Granted Aug 23, 2022·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when FORESEE PHARMACEUTICALS CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →